Fondaparinux (Arixtra)

(Arixtra)

Same efficiency but less bleeding than enoxaparin

Dosage

Acute coronary syndrome: 2,5 mg/day s.c.. Not more than 8 days.

Absolute contra-indications

  • Severe bleeding
  • Hypersensitivity to fondaparinux or excipients
  • Acute endocarditis
  • Severe renal insufficency with clearance < 20 ml/min.

http://www.drugs.com/search.php?searchterm=fondaparinux